SMTL ID : 8qu8.1

PROTAC-mediated complex of KRAS with VHL/Elongin-B/Elongin-C/Cullin-2/Rbx1

Coordinates
PDB Format
Method
ELECTRON MICROSCOPY 3.50 Å
Oligo State
hetero-1-1-1-1-1-1-mer
Ligands
2 x ZN: ZINC ION(Non-covalent)
1 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)
1 x WYL: (2S,4R)-1-[(2S)-2-[4-[4-[(3S)-4-[4-[5-[(4S)-2-azanyl-3-cyano-4-methyl-6,7-dihydro-5H-1-benzothiophen-4-yl]-1,2,4-oxadiazol-3-yl]pyrimidin-2-yl]-3-methyl-1,4-diazepan-1-yl]butoxy]-1,2,3-triazol-1-yl]-3-methyl-butanoyl]-N-[(1R)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-2-oxidanyl-ethyl]-4-oxidanyl-pyrrolidine-2-carboxamide(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Popow, J. et al., Targeting cancer with small molecule pan-KRAS degraders. Biorxiv (2023)
Release Date
2023-12-06
Peptides
von Hippel-Lindau disease tumor suppressor: A
Elongin-B: B
Elongin-C: C
Cullin-2: D
E3 ubiquitin-protein ligase RBX1, N-terminally processed: E
GTPase KRas: F
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B
C
C
D
D
E
E
F
F

von Hippel-Lindau disease tumor suppressor

Elongin-B

Elongin-C

Cullin-2

E3 ubiquitin-protein ligase RBX1, N-terminally processed

GTPase KRas

Related Entries With Identical Sequence

4epx.1 | 4epy.1 | 6xha.1 | 8azz.1 | 8qw6.1 | 8qw6.2 | 8qw7.1 | 8qw7.2